J. Kruse

发表

Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.

R. Desnick, S. Gatt, G. Grabowski, 1984, Archives of biochemistry and biophysics.

23,25-Dihydroxy-24-oxovitamin D3: a metabolite of vitamin D3 made in the kidney.

A. Norman, R. Chandraratna, W. Okamura, 1983, Biochemistry.

Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.

R. Desnick, J. Goldblatt, S. Gatt, 1985, American journal of medical genetics.

Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.

S. Gatt, G. Grabowski, G. Legler, 1985, American journal of human genetics.

Isolation and identification of 1,25-dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3. New metabolites of vitamin D3 produced by a C-24 oxidation pathway of metabolism for 1,25-dihydroxyvitamin D3 present in intestine and kidney.

A. Norman, R. Chandraratna, W. Okamura, 1983, The Journal of biological chemistry.

Isolation and identification of 23,25-dihydroxy-24-oxo-vitamin D3: a metabolite of vitamin D3.

A. Norman, G. Popják, G. Reddy, 1982, Biochemical and biophysical research communications.

Identification of chromosome arms influencing expression of the HMW glutenins in wheat

J. Munkvold, E. Brachman, M. Wanous, 2002, Theoretical and Applied Genetics.

First-trimester prenatal diagnosis of Tay-Sachs disease.

R. Desnick, K. Blakemore, R. Gordon, 1984, American journal of human genetics.

Isolation and chemical characterization of two new vitamin D metabolites produced by the intestine. 1,25-Dihydroxy-23-oxo-vitamin D3 and 1,25,26-trihydroxy-23-oxo-vitamin D3.

A. Norman, G. Popják, N. Ohnuma, 1982, The Journal of biological chemistry.